Sodium Fluoride Activator Concentrate Recalled for Manufacturing Practice Violations
Ecometics, Inc. is recalling 32,583 bottles of Sodium Fluoride 0.96% Activator Concentrate nationwide due to manufacturing practice deviations. The product was not manufactured under current good manufacturing practices (CGMP).
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall due to manufacturing practice deviations. The product was not manufactured under Current Good Manufacturing Practices (CGMP), which constitutes a potential risk of harm to consumers by affecting product quality, purity, and safety assurance. No illnesses or injuries have been reported. Per the rubric, this qualifies as a 'risk-of-harm product where injury has not yet been reported,' warranting a High (3) classification.
Plain-English summary
Ecometics, Inc. is recalling 32,583 bottles of Sodium Fluoride 0.96% Activator Concentrate (Net 1 FL. OZ., Lot 1E175B, expiration 6/24) due to Current Good Manufacturing Practice (CGMP) deviations. The product, manufactured for All USA Direct, LLC in Broadview, Illinois, was not produced under CGMP requirements, which establish the standards for quality, purity, and safety in pharmaceutical manufacturing.
The affected product was distributed nationwide in the United States. The recalled lot number is 1E175B with an expiration date of 6/24.
Consumers who have purchased this product should stop using it and consult their healthcare provider or dentist regarding any previous use. Consumers should dispose of the product safely or return it to the point of purchase.
The recalled product
- Product
- activator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% in diluted Activator Solution, Net 1 FL. OZ., Manufactured for: All USA Direct, LLC, Broadview, IL 60155.
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Dental / Fluoride
- Hazard
- Affected units
- 32,583
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 1E175B
- exp 6/24
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Ecometics, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Ecometics, Inc.
See all →- HighLugol's Strong Iodine Solution Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-08-30
- HighFDA Recalls AstrinGyn Surgical Hemostatic Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- ModerateALCOLADO RELAMPAGO topical liniment recalled for manufacturing process violations
FDA (Drugs) · 2023-08-30
- ModerateUnguentine Ointment Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- HighYager's Liniment Recalled for Manufacturing Practice Violations
FDA (Drugs) · 2023-08-30
Same hazard · manufacturing deviation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
Similar recalls
- ModerateSodium fluoride oral rinse recalled for manufacturing deviations
FDA (Drugs) · 2023-03-15
- HighBaxter Recalls 0.9% Sodium Chloride Injection Due to CGMP Deviations
FDA (Drugs) · 2018-09-05
- ModerateFDA recalls Techni-Care Chloroxylenol antiseptic due to manufacturing deviations
FDA (Drugs) · 2023-02-22
- ModeratePharMEDium Recalls Fentanyl Citrate Due to Expired Diluent
FDA (Drugs) · 2017-09-27
- SevereSodium Chloride Recall Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- ModerateFluoride Dental Product Recalled Due to Label Mix-Up
FDA (Drugs) · 2024-09-18